Clinical trial
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD &…
NCT00151983 · Noven Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00151983 |
|---|---|
| Title | Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy |
| Official title | A Prospective, Open-Label, Multi-Center Study Evaluating the Safety and Tolerability of Methylphenidate Transdermal System (MTS) in Children Aged 6-12 Previously Treated With Extended-Release Methylphenidate Product. |
| Lead sponsor | Noven Therapeutics, Industry |
| Collaborators | Noven Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug |
| Interventions | Methylphenidate Transdermal System |
| Enrollment | 175 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 9, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: